These Stocks Are Expected to See at Least 25% Revenue Growth in 2025 – Wolfe

Seeking Alpha03:09

FDA Issues Draft Guidance on Developing Weight Loss Drugs

Seeking Alpha00:53

Citi Says 'Buy' These Stocks in '25; SA Quant Ratings Says Maybe Not

Seeking Alpha00:17

Eli Lilly's Options: A Look at What the Big Money Is Thinking

BenzingaJan 7 22:45

Express News | Refile-Buzz-Obesity Drugs, M&a Among Key Pharma Drivers for 2025, Berenberg Says

BreakingsJan 7 21:22

Morgan Stanley Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,146

Futu NewsJan 7 19:37 · Ratings